Huntington's disease
Inherited chorea and cognitive decline · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An autosomal dominant neurodegenerative disorder from CAG repeat expansion in the HTT gene, causing progressive chorea, psychiatric disturbance and cognitive decline. Management is symptomatic and multidisciplinary with important genetic counselling implications.
Red flags
- Suicidal ideation (markedly increased risk)
- Rapid cognitive or functional decline
- Severe dysphagia and weight loss
- Depression triggered or worsened by tetrabenazine
- Juvenile (Westphal) variant with rigidity and seizures
Assessment
Differential diagnosis
- Other causes of chorea (Sydenham's, SLE, drug-induced)
- Huntington's disease-like syndromes and neuroacanthocytosis
- Wilson's disease
- Tardive dyskinesia
- Benign hereditary chorea
- Functional movement disorder
Investigations
- Genetic testing for HTT CAG repeat expansion (with counselling)
- MRI brain (caudate atrophy)
- Psychiatric assessment including suicide risk
- Cognitive assessment
- Exclude secondary chorea (autoimmune, metabolic, drug) where presentation atypical
Management
- Recognise the triad of chorea, psychiatric and cognitive features with a relevant family history
- Arrange genetic counselling before any diagnostic or predictive testing
- Confirm diagnosis with HTT gene testing
- Assess and actively manage psychiatric symptoms and suicide risk
- Treat disabling chorea with a VMAT2 inhibitor or antipsychotic
- Provide multidisciplinary support (physiotherapy, speech, dietetics for weight loss)
- Manage dysphagia and nutrition proactively
- Address apathy, irritability and depression
- Discuss reproductive options and predictive testing for relatives
- Plan advance care and palliative support as disease progresses
Drugs & doses
Tetrabenazine 12.5 mg PO daily titrated to effect (up to 100 mg/day) for chorea
Deutetrabenazine 6 mg PO BD titrated to maximum 48 mg/day
Olanzapine or risperidone for chorea with psychiatric symptoms
SSRIs (e.g. sertraline 50-200 mg PO daily) for depression
Valbenazine as alternative VMAT2 inhibitor
Disposition
Specialist Huntington's/movement disorder and genetics service. Multidisciplinary and psychiatric support. Palliative care in advanced disease.
Complications & pitfalls
- Suicide and severe depression
- Aspiration pneumonia
- Weight loss and malnutrition
- Falls and injury
- Progressive dementia and dependency
Exam pearls
- Genetic counselling must precede testing given implications for the patient and family
- Suicide risk is high; screen at every visit
- Tetrabenazine can worsen depression; monitor mood closely
- Weight loss is common; maintain a high-calorie diet
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.